COVID-19 Patients in Japan Improved on Plaquenil (hydroxychloroquine)
A patient with the novel coronavirus disease COVID-19 saw symptoms improve after being treated with Sanofi’s immune modulator Plaquenil (hydroxychloroquine sulfate), according to the latest report